Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
195 participants
INTERVENTIONAL
2000-03-31
2000-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RTF Infant Formula 1
a ready to feed (RTF) extensively hydrolyzed infant formula fed ad lib.
RTF Infant Formula
a RTF extensively hydrolyzed infant formula
Powder Infant Formula 2
a powdered extensively hydrolyzed infant formula fed ad lib.
Powder Infant Formula
a powdered extensively hydrolyzed infant formula.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RTF Infant Formula
a RTF extensively hydrolyzed infant formula
Powder Infant Formula
a powdered extensively hydrolyzed infant formula.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Singleton, term birth with a gestational age of 37 to 42 weeks.
* Birth weight of 2500 g (5 lb 8 oz) or greater.
* Between 0 and 9 days of age at enrollment.
* Not receiving vitamin or mineral supplements.
Exclusion Criteria
9 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlene Borschel, RD, PhD
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Dreyer Medical Center
Aurora, Illinois, United States
PediaResearch, LLC
Evansville, Indiana, United States
The University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Kentucky Pediatric Research
Bardstown, Kentucky, United States
Children's Mercy Hospital
Kansas City, Missouri, United States
NC Children's & Young Adults' Clinical Research Foundation
Chapel Hill, North Carolina, United States
GrandView Medical Research
Sellersville, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AJ57
Identifier Type: -
Identifier Source: org_study_id